These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29526622)

  • 1. Zaleplon loaded bi-layered chronopatch: A novel buccal chronodelivery approach to overcome circadian rhythm related sleep disorder.
    Farag MM; Abd El Malak NS; Yehia SA
    Int J Pharm; 2018 May; 542(1-2):117-124. PubMed ID: 29526622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients.
    Khalifa MKA; Salem HA; Shawky SM; Eassa HA; Elaidy AM
    Drug Deliv; 2019 Dec; 26(1):1243-1253. PubMed ID: 31752566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia.
    Hosny KM; Banjar ZM
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1033-41. PubMed ID: 23795561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Noguchi H; Kitazumi K; Mori M; Shiba T
    J Pharmacol Sci; 2004 Mar; 94(3):246-51. PubMed ID: 15037809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of insomnia with zaleplon, a novel sleep medication.
    Doghramji PP
    Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon.
    Greenblatt DJ; Harmatz JS; Walsh JK; Luthringer R; Staner L; Otmani S; Nedelec JF; Francart C; Parent SJ; Staner C
    Biopharm Drug Dispos; 2011 Dec; 32(9):489-97. PubMed ID: 21935965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
    Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
    Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
    Ansseau M
    Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW; Wickman JM; Augustin SG; Strom JG
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
    Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
    Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
    Janga KY; Jukanti R; Velpula A; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Eur J Pharm Biopharm; 2012 Feb; 80(2):347-57. PubMed ID: 22041602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zaleplon for insomnia.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):93-4. PubMed ID: 10535052
    [No Abstract]   [Full Text] [Related]  

  • 16. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
    Fry J; Scharf M; Mangano R; Fujimori M
    Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
    Whitmore JN; Fischer JR; Storm WF
    Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Targeted Intranasal Zaleplon Nano-emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses.
    Abd-Elrasheed E; El-Helaly SN; El-Ashmoony MM; Salah S
    Curr Drug Deliv; 2018; 15(6):898-906. PubMed ID: 29189154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
    Heydorn WE
    Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.